Scpharmaceuticals Stock Forward View - Polynomial Regression
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
Scpharmaceuticals Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Scpharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of Scpharmaceuticals' stock price is under 61. This usually implies that the stock is rather overbought by investors as of 3rd of February 2026. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Scpharmaceuticals, making its price go up or down. Momentum 61
Buy Extended
Oversold | Overbought |
Using Scpharmaceuticals hype-based prediction, you can estimate the value of Scpharmaceuticals from the perspective of Scpharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of Scpharmaceuticals on the next trading day is expected to be 5.78 with a mean absolute deviation of 0.25 and the sum of the absolute errors of 15.21. Scpharmaceuticals after-hype prediction price | USD 5.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Scpharmaceuticals |
Scpharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Scpharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scpharmaceuticals using various technical indicators. When you analyze Scpharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Scpharmaceuticals Polynomial Regression Price Forecast For the 4th of February
Given 90 days horizon, the Polynomial Regression forecasted value of Scpharmaceuticals on the next trading day is expected to be 5.78 with a mean absolute deviation of 0.25, mean absolute percentage error of 0.11, and the sum of the absolute errors of 15.21.Please note that although there have been many attempts to predict Scpharmaceuticals Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Scpharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Scpharmaceuticals Stock Forecast Pattern
| Backtest Scpharmaceuticals | Scpharmaceuticals Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Scpharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Scpharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.8633 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2493 |
| MAPE | Mean absolute percentage error | 0.0494 |
| SAE | Sum of the absolute errors | 15.2085 |
Predictive Modules for Scpharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scpharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Scpharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Scpharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Scpharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Scpharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Scpharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Scpharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Scpharmaceuticals' historical news coverage. Scpharmaceuticals' after-hype downside and upside margins for the prediction period are 5.67 and 5.67, respectively. We have considered Scpharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Scpharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Scpharmaceuticals is based on 3 months time horizon.
Scpharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Scpharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scpharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Scpharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 4 Events / Month | 6 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.67 | 5.67 | 0.00 |
|
Scpharmaceuticals Hype Timeline
Scpharmaceuticals is at this time traded for 5.67. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Scpharmaceuticals is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Scpharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 5.67. About 80.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.81. Scpharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.Scpharmaceuticals Related Hype Analysis
Having access to credible news sources related to Scpharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Scpharmaceuticals' future price movements. Getting to know how Scpharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Scpharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CLYM | Climb Bio | (3.46) | 23 per month | 5.29 | 0.18 | 14.49 | (8.38) | 42.56 | |
| INZY | Inozyme Pharma | 0.01 | 7 per month | 3.27 | 0.15 | 10.42 | (7.26) | 179.17 | |
| CKPT | Checkpoint Therapeutics | 0.05 | 7 per month | 1.42 | 0.10 | 2.33 | (2.52) | 62.14 | |
| THRD | Third Harmonic Bio | 0.01 | 3 per month | 0.00 | 0.02 | 0.58 | (0.38) | 3.41 | |
| VIGL | Vigil Neuroscience | 0.01 | 8 per month | 1.63 | 0.12 | 5.09 | (2.49) | 241.38 | |
| ORTX | Orchard Therapeutics PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPPI | Spectrum Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LAB | Standard Biotools | (0.06) | 5 per month | 3.37 | 0.04 | 7.81 | (6.12) | 24.04 | |
| TSVT | 2Seventy Bio | (0.01) | 9 per month | 1.06 | 0.14 | 6.69 | (3.47) | 78.00 | |
| SLRN | ACELYRIN INC Common | (0.03) | 8 per month | 4.22 | 0.03 | 5.85 | (5.84) | 35.54 |
Scpharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scpharmaceuticals stock to make a market-neutral strategy. Peer analysis of Scpharmaceuticals could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Scpharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Scpharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scpharmaceuticals shares will generate the highest return on investment. By undertsting and applying Scpharmaceuticals stock market strength indicators, traders can identify Scpharmaceuticals entry and exit signals to maximize returns.
Scpharmaceuticals Risk Indicators
The analysis of Scpharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Scpharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting scpharmaceuticals stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.39 | |||
| Semi Deviation | 2.34 | |||
| Standard Deviation | 3.62 | |||
| Variance | 13.08 | |||
| Downside Variance | 10.22 | |||
| Semi Variance | 5.48 | |||
| Expected Short fall | (2.79) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Scpharmaceuticals
The number of cover stories for Scpharmaceuticals depends on current market conditions and Scpharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Scpharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Scpharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Scpharmaceuticals Short Properties
Scpharmaceuticals' future price predictability will typically decrease when Scpharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Scpharmaceuticals often depends not only on the future outlook of the potential Scpharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scpharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.5 M | |
| Cash And Short Term Investments | 75.7 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |